February 26, 2019
Canada is not a “free rider” on drug pricing according to a new report from the C.D. Howe Institute. In “High Drug Prices, Big R&D Spenders and “Free Riders”: Canada in the Topsy Turvy World of Pharmaceuticals”, authors Åke Blomqvist and Rosalie Wyonch find that relative to its peers, Canada does not free ride on US research and development spending.
